GELS
NASDAQ
$0.59
Gelteq Ltd (GELS)
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.
Sector:
Healthcare
Market Cap
$5.56M
P/B Ratio
0.58
Free Cash Flow Yield
-9.35%
Beta (5Y)
2.38
Price Chart
Valuation
Market Cap$5.56M
P/S12.03
P/B0.58
Profitability
Total Revenue (TTM)$123K
Gross Profit (TTM)$246K
EBITDA-$2.49M
Operating Margin-1985%
EPS-$0.42
Financial Health
Debt-to-Equity36%
Free Cash Flow Yield-9.35%
Growth & Risk
Beta (5Y)2.38
Sharpe Ratio0.17